| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |